A pedagogical view about the design of isoxazolyl-penicillins of the ampc betalactamase receptor 1fcm using the docking molecular technique

Main Article Content

Laura Alejandra Heredia Parra
Edson Armando Vigoya Ovalle https://orcid.org/0000-0003-3270-016X
Astrid Ramírez Valencia https://orcid.org/0000-0002-3025-5982
Luis Eduardo Peña Prieto https://orcid.org/0000-0002-0565-3372

Keywords

Cloxacillin, Isoxazolyl penicillins, Betalactamase, Molecular docking

Abstract

The present work mainly exposes the result of the search for molecules, derived from the structural changes of the drug Cloxacillin in its phenyl radical, which is chlorinated, likewise, the selection of the pharmacophore group is evidenced, which allowed to specify the aforementioned objective. Secondly, the selected target was beta-lactamase, with 1FCM nomenclature, registered in the database, Protein Data Bank, in the same way, the amino acids involved in non-covalent interactions are found, in this order of ideas, they were raised, 22 molecules that presented an affinity energy lower than -8.0 Kcal/mol, this data stated above, will become the reference value, to postulate 6 molecules that have registered a lower affinity, generated by the Autodock Vina software. To conclude, the structural optimization of the leading drug is given as a result, together with its new interactions in the amino acids LYS64, ASN149, THR313 and SER61.

Abstract 274 | PDF Downloads 171

References

Agudelo, C. I., Castañeda, E., Corso, A., Regueira, M., Brandileone, M. C. D. C., Brandão, A. P., & Di Fabio, J. L. (2009). Resistencia a antibióticos no betalactámicos de aislamientos invasores de Streptococcus pneumoniae en niños latinoamericanos: SIREVA II, 2000-2005. Revista Panamericana de Salud Pública, 25, 305-313.

Barcelona, L. M. (2008). Betalactámicos con inhibidores de betalactamasas: Amoxicilina-sulbactam. . Medicina (Buenos Aires).

Bruce N. Ames, E. G. ( 1973). Carcinógenos como mutágenos de cambio de marco: metabolitos y derivados del 2-acetilaminofluoreno y otros carcinógenos de aminas aromáticas. . Carcinógenos como mutágenos de cambio de marco: metabolitos y de PNAS 69

Cantón, R. H. (s.f.). Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. Enfermedades infecciosas y microbiología clínica, . 3.

Choque, C. (1993 ). Antibióticos betalactâmicos. . Rev. Soc. Boliv. Med. Famil, , 91-7.

Cué Brugueras, M. &. (1998 ). Antibacterianos de acción sistémica: Parte I. Antibióticos betalactámicos. Antibacterianos de acción sistémica. Revista Cubana de Medicina General Integral

Curtis, H. &. (2008). Curtis. Biología. Ed. Médica Panamericana.

Ehrlich, P. (1909 ). Present status of chemotherapy. . Ber Dtsch Chem Ges.

Fleming, A. (1929 ). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. British journal of experimental patholog.

Fu, Y. Z. ( 2018). Fu, Insights into the Molecular Mechanisms of Protein-Ligand Interactions by Molecular Docking and Molecular Dynamics Simulation .

Gaba, M. S. (2010). An overview on Molecular Docking. International Journal of Drug Development & Research.

García Castellanos, T., Castillo Marshal, A., & Salazar Rodríguez, D. (2014). Mecanismos de resistencia a betalactámicos en bacterias gramnegativas. Revista Cubana de Salud Pública.

Garcia, J. E. ( 1999). Antibióticos betalactámicos. Antimicrobianos en medicina. Gómez, J. G.-V.-T. (2015). Los betalactámicos en la práctica clínica. . Rev Esp Quimioter.

Gund, P. A. (1980). Three-dimensional molecular modeling and drug design. . Science.

Güner, O. F. ( 2000). Pharmacophore perception, development, and use in drug design . (Vol. 2). Internat’l University Line.

Kumar, K. A. Kumar, KM, Anbarasu, A. y Ramaiah, S. (2014). Estudios de acoplamiento molecular y dinámica molecular de β-lactamasas y proteínas de unión a penicilina. Mol. BioSyst., 10 (4), 891– 900. doi: 10.1039 / c3mb70537d ). Estudios de acoplamiento molecular y dinámica molecular de β-lactamasas y proteínas de unión a penicilina.

Lipman, A. G. ( 1993). MARTINDALE: ‘Martindale—the extra pharmacopoeia. edited by JEF Reynolds. International Journal of Pharmacy Practice,.

Livermore, D. M. ( 1993). Determinants of the activity of β-lactamase inhibitor combinations. Journal of Antimicrobial Chemotherapy, 31(suppl_A), 9-21.

Patera, A., Blaszczak, L., & Shoichet, B. (2020). Crystal structure of the e.coli ampc beta-lactamase mutant q120l/y150e covalently acylated with the inhibitory beta-lactam, cloxacillin. . B.K. : Protein Data Bank.

Prieto-Martínez, F. D.-F. (2018). Molecular docking: current advances and challenges. TIP. . Revista especializada en ciencias químico-biológicas, 21.

Ruvinsky, R. O. ( 2001). Streptococcus pneumoniae: Epidemiología y resistencia a antimicrobianos de las enfermedades invasoras en Latinoamérica. . Revista chilena de infectología, 18, 10-14.

Saldívar-González, F. P.-M.-F. (2017). Descubrimiento y desarrollo de fármacos: un enfoque computacional. . . Educación química, 28(1), 51-58.

Sharon S. Castle, C. E. (2007). The Comprehensive Pharmacology. Pharmacology Reference, Elsevier.

Pages 1-5, ISBN 9780080552323, doi. org/10.1016/B978-008055232-3.61500-4.

Suárez, C. &. (2009). Antibióticos betalactámicos. Enfermedades infecciosas y microbiología clínica.

Trott, O. &. ( 2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. . Journal of computational chemistry, 31(2), 455-461.

Zhong-hua. (2002). Síntesis de cloxacilina sódica. Shanx I. Guardian Pharmaceuticals Co. Ltd, Taiy uan 030021, China.
CIBERGRAFÍA - https://www.rcsb.org/sequence/1fcm -
https://chemdrawdirect.perkinelmer. cloud/js/sample/index.html
https://go.drugbank.com/drugs/ DB01147 ( Targets)
http://en.cnki.com.cn/Article_en/ CJFDTotal-SXDR200203009.html